Press Releases about Altamira Therapeutics Ltd
Altamira Therapeutics Provides Business Update
January 27, 2023
Via GlobeNewswire
Via GlobeNewswire
Altamira Therapeutics Provides Year-End 2022 Business Update
December 19, 2022
Via GlobeNewswire
Altamira Therapeutics Announces Reverse Stock Split
October 24, 2022
Via GlobeNewswire
Altamira Therapeutics to Participate at RNA Leaders USA Congress
October 13, 2022
Via GlobeNewswire
Via GlobeNewswire
Altamira Therapeutics Receives FDA 510(k) Clearance for Bentrio to Treat Allergic Rhinitis
June 27, 2022
Via AccessWire
Exposures
Product Safety
Altamira Therapeutics Achieves COVAMID Trial Target Enrollment for Bentrio in Acute COVID-19
June 23, 2022
Via AccessWire
Exposures
COVID-19
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|